Cargando…

Vitamin D in Acute Campylobacteriosis–Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model

Human Campylobacter infections are progressively rising and of high socioeconomic impact. In the present preclinical intervention study we investigated anti-pathogenic, immuno-modulatory, and intestinal epithelial barrier preserving properties of vitamin D applying an acute campylobacteriosis model....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mousavi, Soraya, Lobo de Sá, Fábia Daniela, Schulzke, Jörg-Dieter, Bücker, Roland, Bereswill, Stefan, Heimesaat, Markus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735268/ https://www.ncbi.nlm.nih.gov/pubmed/31552040 http://dx.doi.org/10.3389/fimmu.2019.02094

Ejemplares similares

Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni
por: Lobo de Sá, Fábia D., et al.
Publicado: (2021)

Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction by Campylobacter jejuni
por: Lobo de Sá, Fábia Daniela, et al.
Publicado: (2019)

Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10(−/−) Mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2020)

Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model
por: Bereswill, Stefan, et al.
Publicado: (2022)

Campylobacter jejuni infection induces acute enterocolitis in IL-10(-/-) mice pretreated with ampicillin plus sulbactam
por: Heimesaat, Markus M., et al.
Publicado: (2022)

Treatment with the Probiotic Product Aviguard(®) Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Resveratrol Prevents Campylobacter jejuni-Induced Leaky gut by Restoring Occludin and Claudin-5 in the Paracellular Leak Pathway
por: Lobo de Sá, F. D., et al.
Publicado: (2021)

Immune-modulatory Properties of the Octapeptide NAP in Campylobacter jejuni Infected Mice Suffering from Acute Enterocolitis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

The Host-Specific Intestinal Microbiota Composition Impacts Campylobacter coli Infection in a Clinical Mouse Model of Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Immune-Mediated Aggravation of the Campylobacter concisus-Induced Epithelial Barrier Dysfunction
por: Nattramilarasu, Praveen Kumar, et al.
Publicado: (2021)

Pituitary Adenylate Cyclase-Activating Polypeptide Alleviates Intestinal, Extra-Intestinal and Systemic Inflammatory Responses during Acute Campylobacter jejuni-induced Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Human microbiota associated IL-10(−/−) mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota
por: Shayya, Nizar W., et al.
Publicado: (2023)

Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis
por: Bereswill, Stefan, et al.
Publicado: (2021)

Campylobacter concisus Impairs Sodium Absorption in Colonic Epithelium via ENaC Dysfunction and Claudin-8 Disruption
por: Nattramilarasu, Praveen Kumar, et al.
Publicado: (2020)

Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome
por: Omarova, Sholpan, et al.
Publicado: (2023)

Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2023)

Contribution of Epithelial Apoptosis and Subepithelial Immune Responses in Campylobacter jejuni-Induced Barrier Disruption
por: Butkevych, Eduard, et al.
Publicado: (2020)

Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Disease alleviating effects following prophylactic lemon and coriander essential oil treatment in mice with acute campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2023)

Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice
por: Du, Ke, et al.
Publicado: (2022)

Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2021)

Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis—Results from a Preclinical Placebo-Controlled Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Therapeutic Oral Application of Carvacrol Alleviates Acute Campylobacteriosis in Mice Harboring a Human Gut Microbiota
por: Foote, Minnja S., et al.
Publicado: (2023)

Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model
por: Mousavi, Soraya, et al.
Publicado: (2020)

Campylobacter jejuni Induces Acute Enterocolitis in Gnotobiotic IL-10(−/−) Mice via Toll-Like-Receptor-2 and -4 Signaling
por: Haag, Lea-Maxie, et al.
Publicado: (2012)

Peroral Clove Essential Oil Treatment Ameliorates Acute Campylobacteriosis—Results from a Preclinical Murine Intervention Study
por: Bereswill, Stefan, et al.
Publicado: (2021)

Protease Activity of Campylobacter jejuni HtrA Modulates Distinct Intestinal and Systemic Immune Responses in Infected Secondary Abiotic IL-10 Deficient Mice
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Comparative genomics of Campylobacter jejuni from clinical campylobacteriosis stool specimens
por: Djeghout, Bilal, et al.
Publicado: (2022)

The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
por: GENGER, CLAUDIA, et al.
Publicado: (2020)

The Role of Gelatinases in Campylobacter Jejuni Infection of Gnotobiotic Mice
por: Alutis, Marie E., et al.
Publicado: (2015)

Campylobacter jejuni infection of conventionally colonized mice lacking nucleotide-oligomerization-domain-2
por: Bereswill, Stefan, et al.
Publicado: (2017)

Immunomodulatory and Antimicrobial Effects of Vitamin C
por: Mousavi, Soraya, et al.
Publicado: (2019)

Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment
por: Ekmekciu, Ira, et al.
Publicado: (2017)

miR-125a-5p regulates the sialyltransferase ST3GAL1 in murine model of human intestinal campylobacteriosis
por: Kraski, Angelina, et al.
Publicado: (2023)

Interleukin-18 Mediates Immune Responses to Campylobacter jejuni Infection in Gnotobiotic Mice
por: Bereswill, Stefan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aivnp3n521afgl6qbd6k4276cu